Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news
FDA clears Xcision Medical ’ s GammaPod breast cancer device
The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer.
The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue.
GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was b...
Source: Mass Device - December 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance xcisionmedicalsystems Source Type: news
Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading:
ASTRO: Breast radiation 'less scary' than expected
JCO releases new sentinel node biopsy guidelines
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news
Why More Women Are Getting a Double Mastectomy
Recent research has shown that despite more having more treatment options, women with cancer in one breast are increasingly choosing to remove both breasts—even though experts in the field say the procedure is not necessarily accompanied by better outcomes.
Now, a new study published Wednesday in JAMA Surgery finds that the increase is being driven in part by their surgeons.
Doctors generally discourage contralateral prophylactic mastectomy—also known as CPM, or the removal of a healthy breast when the other has cancer—for women at an average risk for additional breast cancer. They do recommend it for wo...
Source: TIME.com: Top Science and Health Stories - September 13, 2017 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Breast Cancer breast cancer treatment contralateral prophylactic mastectomy double mastectomy lumpectomy symptoms breast cancer Source Type: news
Dune Medical relocates US HQ to Atlanta
Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device.
The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the company said.
The system uses the company’s proprietary radiofrequency spectroscopy technology to help surgeons identify microscopic residual cancer at surgical margins during surgery.
“Dune’s proprietary technology is already demonstrating high value...
Source: Mass Device - August 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dune Medical Devices Inc. Source Type: news
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
(Wiley) A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news
Effect of Radiotherapy in Breast Cancer Similar Across Subtypes
Breast cancer subtypes generally did not respond differently to radiotherapy following breast-conserving surgery, according to long-term follow-up of a randomized trial. (Source: CancerNetwork)
Source: CancerNetwork - August 5, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Radiation Oncology Source Type: news
Benefit of Radiotherapy After Breast Conservation in DCIS Benefit of Radiotherapy After Breast Conservation in DCIS
Can this molecular assay help determine who will benefit from radiotherapy after breast-conserving therapy for DCIS?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
MRI Plus Mammography Improves Screening After Breast Conservation MRI Plus Mammography Improves Screening After Breast Conservation
Adding MRI or ultrasonography to mammography improves detection of new breast cancers in younger women who have had breast conservation therapy (BCT) for breast cancer, a new study finds.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 28, 2017 Category: Radiology Tags: Radiology News Source Type: news
Adding MRI to Mammography Ups Detection of Breast Cancer
Findings in women aged ≤ 50 years who had undergone breast conservation therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 26, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Radiology, Surgery, Journal, Source Type: news
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
(The JAMA Network Journals) A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2017 Category: Cancer & Oncology Source Type: news
Many TNBC Patients Unnecessarily Opt for Mastectomy
The use of neoadjuvant chemotherapy increases eligibility for breast-conserving therapy in triple-negative breast cancer patients, yet many still opt for mastectomy. (Source: CancerNetwork)
Source: CancerNetwork - June 16, 2017 Category: Cancer & Oncology Authors: Mark Fuerst Tags: Breast Cancer News Triple-Negative Breast Cancer Source Type: news
As bike commuting soars, so do injuries. Annual medical costs are now in the billions.
Bikes have transformed urban landscapes throughout America, from pavement markings on streets to our workday gear, and most of us agree it's a good thing. They've reduced the pollution we send into the ozone layer, helped us conserve gas and oil and kept us fitter than we might otherwise be. But there's also been a downside […]Related:Is pregnancy safe after breast cancer? Here’s what the latest data shows.‘Drug tourists’ keep overdosing at this library. Here’s how employees are saving their lives.Professor who campaigned to ban trans fats dies at 102 (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 3, 2017 Category: Consumer Health News Source Type: news
Combined optical and molecular imaging could guide breast-conserving surgery
(Society of Nuclear Medicine) Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries. Now, in a first-in-human study, British researchers have provided a possible solution using Cerenkov luminescence imaging (CLI), which combines optical and molecular imaging. The study is covered in the featured article of The Journal of Nuclear Medicine's June 2017 issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2017 Category: Cancer & Oncology Source Type: news
Decision Making in the Surgical Management of Invasive Breast Cancer —Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy
Breast-conserving surgery and mastectomy are equivalent treatments for invasive breast cancer patients in terms of overall survival. For the majority of patients, successful breast conservation requires a margin-negative lumpectomy and access to WBRT. CPM yields no definitive survival advantage. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Lisa A. Newman, MD, MPH Tags: Breast Cancer Oncology Journal Review Article Source Type: news
Decision Making in the Surgical Management of Invasive Breast Cancer —Part 2: Expanded Applications for Breast-Conserving Surgery
This article will detail current management approaches to achieving breast conservation in patients with invasive breast cancer, including cases of bulky tumors and/or multiple tumors. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Lisa A. Newman, MD, MPH Tags: Breast Cancer Oncology Journal Review Article Source Type: news
7 medtech stories we missed this week: April 7, 2017
[Image from unsplash.com]New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking.
Here are some medtech stories we missed this week but thought were still worth mentioning.
1. AMNIOX touts new umbilical cord study
AMNIOX Medical announced that it has published the results of 3 studies that demonstrate the effectiveness of umbilical cord tissue for treating chronic wounds, according to an April 7 press release. The company’s cryopreserved human umbilical cord tissue, NEOX Cord 1K was tested on 29 patients who needed a wound all...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Radiosurgery Regulatory/Compliance Research & Development Spinal Wound Care Aesculap Implant Systems Amniox AngioDynamics Cianna Medical InVivo Therapeutics MedTech Nu-Med Occlutech Source Type: news
Breast Conservation Therapy Preferred Local Treatment Option for Stage II Disease
Breast conservation therapy is usually best for local treatment for stage II breast cancer —and biology, as well as stage, drives patient outcomes. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Breast Cancer Conferences/MBCC 2017 News Source Type: news
Older women less likely to be offered breast reconstruction after mastectomy
Guidelines state that surgeons should discuss breast reconstruction with all suitable patients Related items fromOnMedica Tamoxifen linked to reduced contralateral breast cancer risk Big data advances breast cancer research by ‘decades’ Breast conservation beats mastectomy for some patients Schoolboy youngest in UK to undergo mastectomy Study finds overuse of double mastectomy (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 8, 2017 Category: UK Health Source Type: news
Breast Conserving Surgery Plus RT Better Than Mastectomy in Some Patients
A large registry study found that certain breast cancer patients gain a significant survival benefit with breast conserving surgery plus radiation therapy compared with mastectomy (Source: CancerNetwork)
Source: CancerNetwork - February 7, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news
Better Survival After Breast Conservation Than Mastectomy Better Survival After Breast Conservation Than Mastectomy
Performing breast-conserving therapy may offer survival benefits over mastectomy, particularly in older women who have earlier-stage disease and other conditions, suggests a large observational study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
ECC Roundup: Breast Conservation Benefit Varies by Age
(MedPage Today) -- And other reports from the European Cancer Congress (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 31, 2017 Category: Endocrinology Source Type: news
More survive breast cancer without full mastectomy
The largest scientific breast cancer study ever conducted looked at the results of 130,000 patients. The results found that women were a third more likely to survive if they had breast-conserving surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2017 Category: Consumer Health News Source Type: news
Some early breast cancer patients benefit more from breast conservation than from mastectomy
Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date. Researchers report that considerably superior survival, both specific to breast cancer and from any cause of death, was found among certain groups of patients who had had BCT. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 29, 2017 Category: Science Source Type: news
Breast conservation beats mastectomy for some patients
New findings presented at European Cancer Congress Related items fromOnMedica Breast cancer screening One in six breast cancer patients have symptom other than a lump Study finds overuse of double mastectomy Partial radiotherapy suitable for early breast cancer Radiotherapy during breast cancer surgery cuts cost and time (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 29, 2017 Category: UK Health Source Type: news
Some early breast cancer patients benefit more from breast conservation than from mastectomy
(ECCO-the European CanCer Organisation) Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date, presented at ECC2017. Dutch researchers report that considerably superior survival, both specific to breast cancer and from any cause of death, was found among certain groups of patients who had had BCT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2017 Category: Global & Universal Source Type: news
Reoperation Rates 3-Fold Higher After DCIS Than IBC Reoperation Rates 3-Fold Higher After DCIS Than IBC
Patients undergoing breast-conserving surgery had reoperation rates 3 times higher when when their diagnosis was ductal carcinoma in situ (DCIS) than when it was invasive breast cancer (IBC).Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 9, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Potentially avoidable breast cancer surgeries cost patients and health-care system
(University of British Columbia Okanagan campus) A recent study by UBC medical researchers examined the health care costs associated with lumpectomy patients requiring reoperations. A lumpectomy, known as breast conservation surgery, is a procedure that removes tumors, aims to conserve breast tissue, and is followed by radiation therapy.The study concluded that with Canadian reoperation rates being more than double recommended targets, the additional cost to BC's health care system alone is $2 million per year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 15, 2016 Category: Cancer & Oncology Source Type: news
Local Recurrence Less Likely With Mastectomy in Younger Breast Cancer Patients
Over the long term, local recurrence is more likely in young women with invasive breast cancer who undergo breast conserving surgery compared with those who undergo mastectomy, though survival is no different. (Source: CancerNetwork)
Source: CancerNetwork - December 12, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Conferences/SABCS 2016 Source Type: news
Advances in treatment may mean women with breast cancer should be spared mastectomies
Professor Mike Dixon, consultant surgeon at the Edinburgh Breast Unit, said breast-conserving surgery, which involves removing the lump and having drug therapy, has ‘better outcomes’. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2016 Category: Consumer Health News Source Type: news
Repeat Breast Conservation Safe, Effective (CME/CE)
(MedPage Today) -- Low recurrence rate, high survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 30, 2016 Category: Hematology Source Type: news
How much is enough: two new priority review updates on radiotherapy for breast cancer
Reposted with permission from Cochrane AustraliaFor many women with breast cancer, the use of post-operative radiotherapy will allow them to undergo less extensive surgery. In mid-July, Brisbane-based Radiation Oncologist Brigid Hickey and colleagues from Australia and New Zealand published two review updates that consider critical questions about the size of the doses in which radiation is given. Here, Brigid shares her thoughts on the important findings of both reviews.‘So who gets breast cancer? Women with families, women with jobs, women with busy lives,’ says Brigid. ‘So from a patient perspect...
Source: Cochrane News and Events - September 26, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news
After long-term follow-up, study looks at prognostic factors for breast cancer
A new study represents a long-term analysis of prognostic factors among some patients with breast cancer who were treated with breast-conserving therapy in the EORTC " boost no boost " trial, which evaluated the influence of a " boost " dose in radiotherapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 8, 2016 Category: Science Source Type: news
After long-term follow-up, study looks at prognostic factors for breast cancer
(The JAMA Network Journals) A new study published online by JAMA Oncology is long-term analysis of prognostic factors among some patients with breast cancer who were treated with breast-conserving therapy in the EORTC 'boost no boost' trial, which evaluated the influence of a 'boost' dose in radiotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 8, 2016 Category: Cancer & Oncology Source Type: news
New Study Shows Lumpectomy With Radiation Therapy to Treat Breast Cancer in a Community Setting Results in Higher Than Average Patient Survival Rates
Manhattan Beach, Cali. (August 25, 2016) – A recently published study in The Journal of Community and Supportive Oncology identifies two key research findings regarding breast cancer treatment options. First, breast conservation treatment (BCT), i.e. lumpectomy plus radiation therapy, delivered in a... (Source: McKesson News)
Source: McKesson News - August 25, 2016 Category: Information Technology Source Type: news
Dune Medical lands $3.4m EU grant
Dune Medical Devices said today it won a $3.4 million (EU €3 million) European Union Horizon 2020 research grant.
The company said it is 1 of 65 companies selected to receive funding from the $91 billion (EU €80 billion) 7-year program aiming to “secure Europe’s global competitiveness.”
“This 3 million euro grant will expedite bringing our soft tissue biopsy system to the market. It will provide radiologists and surgeons immediate graphic characterizations of tissue abnormalities along the tip of the biopsy needle, just before samples are taken. This real-time insight can help reduce ...
Source: Mass Device - August 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics Oncology Dune Medical Devices Inc. Source Type: news
Guidelines Establish Minimum Negative Margins in DCIS
Three medical organizations including ASCO have issued a guideline on margins in breast conserving surgery for patients with ductal carcinoma in situ. (Source: CancerNetwork)
Source: CancerNetwork - August 18, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Breast Cancer News Source Type: news
FDA adds new clearance for Cianna Medical ’ s Savi Scout breast cancer locator
Cianna Medical said today it won additional FDA 510(k) clearance for its Savi Scout radar localization breast cancer device, now cleared to be placed at the lumpectomy site up to 30 days prior to surgical removal.
Aliso Viejo, Calif.-based Cianna’s Savi Scout is designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures.
The surgeon uses a hand piece that emits infrared light and electromagnetic waves to locate a reflector placed in target tissue as long as a week before surgery. After reaching the surgical bulls-eye, the surgeon takes out the ta...
Source: Mass Device - August 17, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Cianna Medical Source Type: news
New DCIS consensus guideline could curb unnecessary breast surgery and reduce health system costs
(American Society for Radiation Oncology) Three leading national cancer organizations today issued a consensus guideline for physicians treating women who have ductal carcinoma in situ (DCIS) treated with breast-conserving surgery with whole breast irradiation. The new guideline has the potential to save many women from unnecessary surgeries while reducing costs to the health care system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 15, 2016 Category: Cancer & Oncology Source Type: news
SAVI SCOUT Targets Breast Tumors
TAMPA, Fla. (Ivanhoe Newswire) -- More than 150,000 women have breast reconstruction surgery and breast conserving surgery every year. Thirty percent may require repeat surgeries. But there’s new technology that could lower those numbers. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - July 13, 2016 Category: Consumer Health News Source Type: news
Revisiting Neoadjuvant Hormones for ER+ Breast Cancer (CME/CE)
(MedPage Today) -- Improved response, breast-conservation rates versus chemotherapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 3, 2016 Category: Hematology Source Type: news
Scientists Seek Ban On Monsanto's RoundUp
On Tuesday, a delegation of independent scientists urged the EPA to ban RoundUp, Monsanto's flagship herbicide at the O'Neill House Office Building in Washington D.C. Providing testimony that it poses an unreasonable risk to humans, animals, and the environment, scientists spoke at a closed meeting with EPA scientists and host Ted Lieu, (CA-33). The scientists explained the physiological reasons why exposure to glyphosate, the active ingredient in RoundUp, is linked to autism, Alzheimer's, cancer, birth defects, obesity, gluten intolerance, among other health issues.*
300 million pounds of RoundUp are sprayed each year on...
Source: Healthy Living - The Huffington Post - June 16, 2016 Category: Consumer Health News Source Type: news
Revamped Technique for Ventral Hernias: The General Surgery News Report
(MedPage Today) -- Also, reoperations after breast-conserving surgery remain high (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 4, 2016 Category: Primary Care Source Type: news
Age May Affect Outcomes With Breast Surgery (CME/CE)
(MedPage Today) -- Local recurrence increased after breast conservation in younger patients (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 3, 2016 Category: Geriatrics Source Type: news
Is breast conserving therapy or mastectomy better for early breast cancer?
Young women with early breast cancer face a difficult choice about whether to opt for a mastectomy or breast conserving therapy (BCT). New research has shown young women, who had early stage breast cancer that had not spread to the lymph nodes and who opted for BCT with radiation therapy, had a 13 percent higher risk of developing a local recurrence of their disease over a 20-year period than women who had a mastectomy and no radiation therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 30, 2016 Category: Science Source Type: news
Is breast conserving therapy or mastectomy better for early breast cancer?
(European Society for Radiotherapy and Oncology (ESTRO)) Young women with early breast cancer face a difficult choice about whether to opt for a mastectomy or breast conserving therapy (BCT). New research presented at the ESTRO 35 conference has shown young women, who had early stage breast cancer that had not spread to the lymph nodes and who opted for BCT with radiation therapy, had a 13 percent higher risk of developing a local recurrence of their disease over a 20-year period than women who had a mastectomy and no radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 29, 2016 Category: Cancer & Oncology Source Type: news
NCCN: Shorter RT Course 'Preferred' for Breast ConservationNCCN: Shorter RT Course 'Preferred' for Breast Conservation
The latest NCCN guidelines for breast cancer urge the use of hypofractionation, in which radiation is delivered for 3 rather than 5 weeks. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
FDA OKs improved MarginProbe device from Dune Medical
Dune Medical Devices said today it won pre-market approval from the FDA for modifications to its MarginProbe breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries.
Modifications to the Paoli, Penn.-based company’s device were made to conform to recent changes in the European Union’s Restriction of Hazardous Substances requirements, Dune Medical said. The company said it expects the U.S. to adopt similar requirements in the future.
“We are continuing to listen to our customers by investing in technology to enhance MarginProbe. Once completed, these cha...
Source: Mass Device - March 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Pre-Market Approval (PMA) Regulatory/Compliance Women's Health Dune Medical Devices Inc. Source Type: news
